Track funded life science companies, founders and investors across the UK startup ecosystem.
| Date | Startup | Funding | Round | Sector | Location | Connect | Website | Investor1 | Investor2 | Investor3 | Investor4 | Investor5 | Founder(s) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10 Nov 2026 | Neobe Neobe develops engineered bacteria that colonise tumours and release enzyme... | £5,060,000 US$6,800,000 | |||||||||||
10 Nov 2026 | Oyster Therapeutics Oyster Therapeutics develops an oral tau degrader using its SELFTAC platfor... | £44,680,000 US$60,000,000 | |||||||||||
9 Nov 2026 | PhaSER Biomedical PhaSER Biomedical offers the 8HUM humanised mouse platform and supporting c... | £2,000,000 | |||||||||||
6 Nov 2026 | bio.bit bio.bit supplies human cell models and an opti-ox platform that programs ce... | £18,570,000 US$25,000,000 | |||||||||||
5 Nov 2026 | FluoRok A manufacturing platform that produces fluorochemicals without hydrogen flu... | £22,270,000 US$30,000,000 | |||||||||||
5 Nov 2026 | T-Therapeutics T-Therapeutics develops therapies that use a platform to supply fully human... | £100,000,000 | |||||||||||
5 Nov 2026 | Alethio Therapeutics ATX-011 is a monoclonal antibody that binds a disease-associated cell surfa... | £67,000,000 | |||||||||||
3 Nov 2026 | OSSTEC ASCENT is a cementless partial knee implant made using 3D-printed component... | £5,970,000 US$8,000,000 | |||||||||||
3 Nov 2026 | Viridi Vireya is an anionic surfactant made from captured carbon dioxide using Vir... | £2,200,000 | |||||||||||
16 Oct 2026 | Microbiotica MB310 is an oral once-daily live biotherapeutic capsule containing eight sp... | £36,000,000 | |||||||||||
16 Oct 2026 | OMass Therapeutics OMS1620 is a small-molecule drug that binds the MC2 receptor to modify rece... | £233,750,000 US$310,000,000 | |||||||||||
15 Oct 2026 | Silvia Bio Silvia Bio provides a cell profiling platform that maps cell behaviour duri... | £3,000,000 | |||||||||||
14 Oct 2026 | Nami Surgical A miniaturised ultrasonic scalpel designed for integration with wristed rob... | £3,400,000 | |||||||||||
14 Oct 2026 | HydRegen HydRegen provides a bio-based hydrogenation platform that formulates enzyme... | £6,040,000 US$8,000,000 | |||||||||||
13 Oct 2026 | Undecimal Bio DELiveri is a platform that uses chemical screening and machine learning to... | £14,000,000 | |||||||||||
8 Oct 2026 | Neela Biotech A process using AI to guide microbial communities that convert organic wast... | £2,100,000 | |||||||||||
6 Oct 2026 | Sensible Biotechnologies A cell-based platform that produces naturally modified mRNA using engineere... | £35,550,000 US$47,000,000 | |||||||||||
5 Oct 2026 | Living Optics Living Optics makes a compact hyperspectral camera platform that combines o... | £15,110,000 US$20,000,000 | |||||||||||
29 Sept 2026 | 52North Neutrocheck is a rapid finger prick blood test that uses a biomarker detect... | £3,200,000 | |||||||||||
29 Sept 2026 | Inovus Medical Inovus Medical makes surgical simulators that combine lifelike anatomical m... | £15,000,000 | St Helens | ||||||||||
24 Sept 2026 | Basecamp Research Basecamp Research offers a drug discovery platform that combines genetic da... | £105,630,000 US$140,000,000 | |||||||||||
24 Sept 2026 | IMS Solutions ACCelerate is a urine diagnostic test that measures steroid biomarkers and ... | £1,100,000 | |||||||||||
22 Sept 2026 | SageTech Medical SageTech Medical supplies a recycling system for waste anaesthetic in hospi... | £2,500,000 | Devon | ||||||||||
18 Sept 2026 | Big Picture Bio Big Picture Bio provides a platform that uses AI to model disease and propo... | £1,500,000 | |||||||||||
17 Sept 2026 | Chemify Chemify provides an automated chemistry discovery platform combining labora... | £22,000,000 | |||||||||||
17 Sept 2026 | MicroLub A protein-based ingredient that replaces fat's lubricating role with water ... | £7,500,000 | |||||||||||
17 Sept 2026 | Eterna Regeneratives A keratin scaffold that forms a thin layer on tooth and bone surfaces. It i... | ||||||||||||
16 Sept 2026 | Axo Longevity Axo Longevity is a membership service that provides regular blood panels, a... | £3,710,000 US$5,000,000 | |||||||||||
15 Sept 2026 | Athernal Bio Athernal Bio develops targeted immunotherapies that recognise and remove hi... | £700,000 | |||||||||||
15 Sept 2026 | Magnitude Biosciences VivoScan is a platform that tests chemical compounds in living C. elegans u... | £1,300,000 |

1 Explore 262 UK life science startups and their founders, who have collectively raised £6.93B.
2 Easily sort, filter, and compare the UK's top startups — customise the list to your needs.
3 Discover top startups for investment, B2B sales, partnerships, hiring, and industry connections.
You can connect with fast-growing life science startups with the full list of recently funded startups from the UK.
With UK-based startups such as Exscientia, BenevolentAI, and Healx, the UK's life sciences sector has rapidly emerged as a hub for innovative healthcare solutions. Driven by advancements in biotechnology, artificial intelligence, and personalised medicine, life science startups are transforming approaches to drug discovery, diagnostics, and patient care.
Life science startups are companies that focus on developing technologies and solutions to advance healthcare, medicine, and biological research. They operate at the intersection of biology and technology, aiming to address complex challenges in health and disease through innovative approaches.
These startups often leverage cutting-edge technologies such as artificial intelligence, machine learning, and genomics to accelerate drug discovery, improve diagnostic accuracy, and personalise treatment plans. By integrating multidisciplinary expertise, they contribute to the development of novel therapies, medical devices, and healthcare platforms.
With substantial funding and support from the scientific community and life science investors, the ecosystem continues to expand rapidly. Let’s explore the key areas currently driving innovation within life science startups:
Life science startups in the UK are pioneering advancements across various domains by harnessing technological innovations and scientific research. Here are five distinct categories of life science startups:
Companies utilising artificial intelligence to streamline the drug discovery process, reducing time and costs associated with bringing new medications to market (examples: Exscientia, BenevolentAI).
Startups focusing on tailoring medical treatments to individual patients based on genetic, environmental, and lifestyle factors, enhancing treatment efficacy and reducing adverse effects (examples: Healx, Congenica).
Companies developing advanced tools and platforms to support biological research and development, facilitating breakthroughs in understanding diseases and developing new therapies (examples: Sphere Fluidics, Oxford Nanopore Technologies).
Startups creating digital solutions to improve patient care, enhance healthcare delivery, and enable remote monitoring and consultations (examples: Cera Care, Babylon Health).
Companies specialising in developing diagnostic tests and identifying biomarkers for early detection and monitoring of diseases, improving patient outcomes through timely intervention (examples: Dxcover, Mologic).